• Western blot analysis of lysates from HT-29, NIH/3T3, and HepG2 cells, primary antibody was diluted at 1:1000, 4°C over night, secondary antibody (cat: (NA) was diluted at 1:10000, 37°C 1hour.

Anti-PDCD6IP antibody (410-490 aa) (STJ194755)

SKU:
STJ194755

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Rat/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Programmed cell death 6-interacting protein (410-490 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
ELISA-Pep 1:5000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PDCD6IP
Gene ID: 10015
Uniprot ID: PDC6I_HUMAN
Immunogen Region: 410-490 aa
Specificity: This antibody detects endogenous levels of human Alix
Immunogen: Synthesized peptide derived from the human Alix at the amino acid range 410-490
Function Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis. Adapter for a subset of ESCRT-III proteins, such as CHMP4, to function at distinct membranes. Required for completion of cytokinesis. May play a role in the regulation of both apoptosis and cell proliferation. Regulates exosome biogenesis in concert with SDC1/4 and SDCBP. By interacting with F-actin, PARD3 and TJP1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier. (Microbial infection) Involved in HIV-1 virus budding. Can replace TSG101 it its role of supporting HIV-1 release.this function requires the interaction with CHMP4B. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as enveloped virus budding (HIV-1 and other lentiviruses).
Protein Name Programmed Cell Death 6-Interacting Protein
Pdcd6-Interacting Protein
Alg-2-Interacting Protein 1
Alg-2-Interacting Protein X
Hp95
Database Links Reactome: R-HSA-162588
Reactome: R-HSA-5210891
Reactome: R-HSA-5213460
Reactome: R-HSA-5675482
Cellular Localisation Cytoplasm
Cytosol
Melanosome
Cytoskeleton
Microtubule Organizing Center
Centrosome
Secreted
Extracellular Exosome
Cell Junction
Tight Junction
Midbody
Midbody Ring
Identified By Mass Spectrometry In Melanosome Fractions From Stage I To Stage Iv
Colocalized With Cep55 At Centrosomes Of Non-Dividing Cells
Component Of The Actomyosin-Tight Junction Complex
Pdcd6ip Targeting To The Midbody Requires The Interaction With Cep55
Alternative Antibody Names Anti-Programmed Cell Death 6-Interacting Protein antibody
Anti-Pdcd6-Interacting Protein antibody
Anti-Alg-2-Interacting Protein 1 antibody
Anti-Alg-2-Interacting Protein X antibody
Anti-Hp95 antibody
Anti-PDCD6IP antibody
Anti-AIP1 antibody
Anti-ALIX antibody
Anti-KIAA1375 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance